Pošalji slijedeće na WhatsApp
Nastavi za razgovorhttps://www.zonebourse.com/cours/action/DIUL-GROUP-25531374/actualite/Diurnal-Group-plc-annonce-le-dosage-du-premier-patient-de-l-essai-clinique-pivot-de-phase-3-Connect-40606258/?utm_source=whatsapp&utm_medium=social&utm_campaign=share